{"id":"W2006709656","doi":"10.1038/sj.bjc.6603055","title":"Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Erlotinib; Medicine; Rash; Internal medicine; Colorectal cancer; Cancer; Epidermal growth factor receptor; Adverse effect; Oncology; Gastroenterology; Progressive disease; Phases of clinical research; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001022297,0.001522636,0.002208264,0.0003906543,0.0003082173,0.0006198457,0.0005150749,0.0007614379,0.002185224],"category_scores_gemma":[0.0006259116,0.0005055083,0.0007531794,0.0003410327,0.0006459518,0.0004154617,0.0002558456,0.0014685,0.0005656543],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007545965,"about_ca_system_score_gemma":0.001283606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001110643,"about_ca_topic_score_gemma":0.002501466,"domain_scores_codex":[0.9996879,0.0001437116,0.00001368087,0.00004305594,0.00003483765,0.00007689567],"domain_scores_gemma":[0.9996145,0.00005406851,0.00005916427,0.00002842322,0.00003119478,0.0002126696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6186276,0.07345847,0.01827485,0.001247793,0.001431592,0.0009113355,0.0003381683,0.004135467,0.1079032,0.0003670446,0.004859308,0.1684453],"study_design_scores_gemma":[0.3582563,0.5991831,0.02723967,0.00002822975,0.0004518967,0.0006669263,0.00007042079,0.001781264,0.00785981,0.000121241,0.004304735,0.00003646365],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941317,0.00179967,0.0004621993,0.000218596,0.00007582409,0.001623679,0.0005803858,0.00005675708,0.001051201],"genre_scores_gemma":[0.9887299,0.002116914,0.001320767,0.0005057849,0.0001719741,0.002390129,0.002126368,0.00002032393,0.002617936],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002208264,"threshold_uncertainty_score":0.007310331,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01175758132970531,"score_gpt":0.3057892982061223,"score_spread":0.294031716876417,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}